Skip to main content
SpringerLink
Log in

Idiopathische Lungenfibrose

Neuer medikamentöser Ansatz bei IPF ist in Studie erfolgreich

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Gagnon et al. A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84. Am J Pathol. 2018;188(5):1132–48

    Article  CAS  PubMed  Google Scholar 

  2. Behr et al. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med. 2016;4(6):445–53

    Article  CAS  PubMed  Google Scholar 

  3. Ogura et al. Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2015;45(5):1382–92

    Article  CAS  PubMed  Google Scholar 

Originalie

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik V, Pneumologie Herz-Thorax-Zentrum Fulda, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Deutschland

    Philipp Markart (Direktor, Stellvertretender Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

  2. Universitätsklinikum Gießen Marburg GmbH, Klinikstrasse 36, 35392, Gießen, Deutschland

    Philipp Markart (Direktor, Stellvertretender Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“) &  Andreas Günther (Chefarzt, Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

  3. AGAPLESION Pneumologische Klinik, Waldhof-Elgershausen, 35753, Greifenstein, Deutschland

    Andreas Günther (Chefarzt, Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

Authors
  1. Philipp Markart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philipp Markart.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markart, P., Günther, A. Neuer medikamentöser Ansatz bei IPF ist in Studie erfolgreich. Pneumo News 11, 15–16 (2019). https://doi.org/10.1007/s15033-019-1239-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-019-1239-1

Search

Navigation